Trevi Therapeutics, Inc. (TRVI): Weighted Average Diluted Shares
134.75M
Year ended 2025-12-31
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 134.75M | +32.1% | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | 101.97M | +3.0% | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | 99.03M | n/c | 2025-03-18, From 2023-01-01 |
| 2022-12-31 | 64.54M | +182.6% | 2024-03-20, From 2022-01-01 |
| 2021-12-31 | 22.84M | n/a | 2023-03-16, From 2021-01-01 |